series-a
Stage
2018
Founded
2
Investors
About
Biotangents develops rapid, molecular diagnostic tests for infectious diseases in livestock, focusing initially on bovine viral diarrhea and mastitis. Their technology enables lab-quality results directly on farms or in veterinary clinics within under two hours.
Explore Biotangents's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.